Literature DB >> 23215903

Maternal recall of hypertensive disorders in pregnancy: a systematic review.

Jennifer J Stuart1, C Noel Bairey Merz, Sarah L Berga, Virginia M Miller, Pamela Ouyang, Chrisandra L Shufelt, Meir Steiner, Nanette K Wenger, Janet W Rich-Edwards.   

Abstract

BACKGROUND: Hypertensive disorders in pregnancy are risk markers for future maternal coronary heart disease (CHD). Clinical assessment of a woman's history of pregnancy complications relies on self-report, but the predictive value of maternal recall is unclear. A systematic review was conducted to comprehensively review and critically assess the available literature on maternal recall of hypertensive disorders in pregnancy.
METHODS: The PubMed, EMBASE, and Web of Science databases were searched through August 2012. We included original research articles comparing maternal recall of hypertensive disorders in pregnancy with medical records.
RESULTS: Ten studies met eligibility criteria for qualitative analysis and were independently reviewed by two investigators. Recall periods ranged from 48 hours to 30 years. Length of recall did not appear to uniformly affect recall quality. Sensitivity was generally lower and less consistent for gestational hypertension than for preeclampsia. Specificity was >90% for all hypertensive disorders. Determinants of recall accuracy included maternal education and parity.
CONCLUSIONS: Although maternal recall of hypertensive disorders of pregnancy is specific, low sensitivity and predictive values may limit the clinical utility of asking mothers to recall their history of hypertensive pregnancy complications. Future research on maternal recall of pregnancy complications should be designed to yield predictive values and test recall of disorder subtypes, recurrent complications, and changing recall over time in the same population. The utility of gestation length and offspring birth weight for clinical identification of women whose pregnancy history puts them at increased CHD risk should also be explored.

Entities:  

Mesh:

Year:  2012        PMID: 23215903     DOI: 10.1089/jwh.2012.3740

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN: 1540-9996            Impact factor:   2.681


  48 in total

1.  The Relationship of Restless Legs Syndrome to History of Pregnancy-Induced Hypertension.

Authors:  Kim E Innes; Sahiti Kandati; Kathryn L Flack; Parul Agarwal; Terry Kit Selfe
Journal:  J Womens Health (Larchmt)       Date:  2016-02-25       Impact factor: 2.681

Review 2.  Adverse pregnancy outcomes and cardiovascular risk factor management.

Authors:  Puja K Mehta; Margo Minissian; C Noel Bairey Merz
Journal:  Semin Perinatol       Date:  2015-07-06       Impact factor: 3.300

3.  Reproductive History and Cognitive Aging: The Bogalusa Heart Study.

Authors:  Emily W Harville; Jack Guralnik; Maryellen Romero; Lydia A Bazzano
Journal:  Am J Geriatr Psychiatry       Date:  2019-07-05       Impact factor: 4.105

4.  Electronic Algorithm Is Superior to Hospital Discharge Codes for Diagnoses of Hypertensive Disorders of Pregnancy in Historical Cohorts.

Authors:  Natasa M Milic; Elisabeth Codsi; Yvonne S Butler Tobah; Wendy M White; Andrea G Kattah; Tracey L Weissgerber; Mie Saiki; Santosh Parashuram; Lisa E Vaughan; Amy L Weaver; Marko Savic; Michelle M Mielke; Vesna D Garovic
Journal:  Mayo Clin Proc       Date:  2018-12       Impact factor: 7.616

5.  Hypertensive Disorders of Pregnancy and 10-Year Cardiovascular Risk Prediction.

Authors:  Jennifer J Stuart; Lauren J Tanz; Nancy R Cook; Donna Spiegelman; Stacey A Missmer; Eric B Rimm; Kathryn M Rexrode; Kenneth J Mukamal; Janet W Rich-Edwards
Journal:  J Am Coll Cardiol       Date:  2018-09-11       Impact factor: 24.094

6.  Pregnancy Complications as Markers for Subsequent Maternal Cardiovascular Disease: Validation of a Maternal Recall Questionnaire.

Authors:  Ebony Boyce Carter; Jennifer J Stuart; Leslie V Farland; Janet W Rich-Edwards; Chloe A Zera; Thomas F McElrath; Ellen W Seely
Journal:  J Womens Health (Larchmt)       Date:  2015-05-20       Impact factor: 2.681

7.  Validation of self-reported maternal and infant health indicators in the Pregnancy Risk Assessment Monitoring System.

Authors:  Patricia Dietz; Jennifer Bombard; Candace Mulready-Ward; John Gauthier; Judith Sackoff; Peggy Brozicevic; Melissa Gambatese; Michael Nyland-Funke; Lucinda England; Leslie Harrison; Allan Taylor
Journal:  Matern Child Health J       Date:  2014-12

8.  Perfluoroalkyl substances during pregnancy and validated preeclampsia among nulliparous women in the Norwegian Mother and Child Cohort Study.

Authors:  Anne P Starling; Stephanie M Engel; David B Richardson; Donna D Baird; Line S Haug; Alison M Stuebe; Kari Klungsøyr; Quaker Harmon; Georg Becher; Cathrine Thomsen; Azemira Sabaredzovic; Merete Eggesbø; Jane A Hoppin; Gregory S Travlos; Ralph E Wilson; Lill I Trogstad; Per Magnus; Matthew P Longnecker
Journal:  Am J Epidemiol       Date:  2014-02-20       Impact factor: 4.897

9.  Postpregnancy BMI in the Progression From Hypertensive Disorders of Pregnancy to Type 2 Diabetes.

Authors:  Simon Timpka; Jennifer J Stuart; Lauren J Tanz; Frank B Hu; Paul W Franks; Janet W Rich-Edwards
Journal:  Diabetes Care       Date:  2018-11-19       Impact factor: 19.112

Review 10.  Maternal preeclampsia and risk for cardiovascular disease in offspring.

Authors:  Guadalupe Herrera-Garcia; Stephen Contag
Journal:  Curr Hypertens Rep       Date:  2014-09       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.